Genomic surveillance and meningococcal group B vaccine coverage estimates after introduction of the vaccine into the national immunisation programme in the UK
Sign Up to like & getrecommendations! Published in 2017 at "The Lancet"
DOI: 10.1016/s0140-6736(17)30481-6
Abstract: Abstract Background In September, 2015, the meningococcal group B vaccine (Bexsero, GlaxoSmithKline) was introduced into the UK childhood immunisation schedule. Prelicensure coverage estimates used Meningococcal Antigen Typing System (MATS) to determine phenotype and function of… read more here.
Keywords: coverage estimates; meningococcal group; family; group vaccine ... See more keywords